[Camphor preparations in the overall therapy of cerebral infarct].
The authors studied the platelet functional properties and the brain bioelectric activity in 20 patients with acute cerebrovascular diseases before and after subcutaneous injection of 2.0 ml of racemic camphor T, as well as before and after oral taking of monobromated camphor in a dose of 0.5 g 3 times a day. The platelet aggregation was examined by the method of Born (1962) with automatic recording of aggregatograms. The brain bioelectric activity was examined using an Alvar electroencephalograph. As a result, the authors discovered an inhibitory effect of camphor preparations on the platelet aggregation. Racemic camphor T and monobromated camphor were found to produce a stimulant effect on the brain.
D001792:Blood Platelets / Q000187:drug effects; D002164:Camphor / Q000008:administration & dosage / Q000627:therapeutic use*; D002544:Cerebral Infarction / Q000188:drug therapy*; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002986:Clinical Trials as Topic; D004562:Electrocardiography; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy; D010974:Platelet Aggregation / Q000187:drug effects
D002164:Camphor
Preparaty kamfory v kompleksnoĭ terapii bol'nykh s mozgovym infarktom.